Table 1.
Group | Immunization | Necropsy | |||
---|---|---|---|---|---|
#1 | #2 | #3 | Main | Recovery | |
Day 1 | Day 22–23 | Day 43 | Day 57 | Day 86 | |
1. CRM/Alum | 0.065 mg/dose | 0.065 mg/dose | 0.065 mg/dose | 5 M,5F | 5 M,5F |
2. J8-CRM + K4S2-CRM/Alum | 0.1 mg/dose | 0.1 mg/dose | 0.1 mg/dose | 5 M,5F | 5 M,5F |
3. p*17-CRM + K4S2-CRM/Alum | 0.1 mg/dose | 0.1 mg/dose | 0.1 mg/dose | 5 M,5F | 5 M,5F |
Alum, aluminum hydroxide adjuvant; CRM, cross-reacting material 197; M, male; F, female.